Structure
Last updated: 2024 Nov 18
Total hit(s): 3314
S.No.
1
39277919
SARS-CoV-2 detection in COVID-19 patients' sample using Wooden quoit conformation structural aptamer (WQCSA)-Based electronic bio-sensing system.
Biosens Bioelectron
2025 Jan 1
9.52
1
2
39489230
Structural basis of the C-terminal domain of SARS-CoV-2 N protein in complex with GMP reveals critical residues for RNA interaction.
Bioorg Med Chem Lett
2024 Dec 1
4.9
1
3
38465692
Surveillance of SARS-CoV-2 in wastewater by quantitative PCR and digital PCR: a case study in Shijiazhuang city, Hebei province, China.
Emerg Microbes Infect
2024 Dec
5.84
1
4
38916498
"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.
Emerg Microbes Infect
2024 Dec
5.84
1
5
39188530
Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39.
J Struct Biol X
2024 Dec
1
6
38953857
A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2.
Emerg Microbes Infect
2024 Dec
5.84
1
7
38086763
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
J Enzyme Inhib Med Chem
2024 Dec
8.6
1
8
38304547
Binding affinity between coronavirus spike protein and human ACE2 receptor.
Comput Struct Biotechnol J
2024 Dec
5.11
1
9
39226846
Eugenol's electrochemical behavior, complexation interaction with copper chloride, antioxidant activity, and potential drug molecular docking application for Covid-19.
Colloids Surf B Biointerfaces
2024 Dec
1
10
39525081
Revealing SARS-CoV-2 M(pro) mutation cold and hot spots: Dynamic residue network analysis meets machine learning.
Comput Struct Biotechnol J
2024 Dec
5.11
1
11
39259045
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages.
Emerg Microbes Infect
2024 Dec
5.84
1
12
39087555
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium.
Emerg Microbes Infect
2024 Dec
5.84
1
13
39541975
The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity.
Structure
2024 Nov 8
9.2
1
14
39502019
Immunometabolic Effect of Nitric Oxide on Human Macrophages Challenged With the SARS-CoV2-Induced Cytokine Storm. A Fluxomic Approach.
Adv Healthc Mater
2024 Nov 6
1
15
39504245
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
Cell Rep
2024 Nov 5
7.7
1
16
39494911
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
J Virol
2024 Nov 4
4.16
1
17
39531907
Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.
Biochem Biophys Res Commun
2024 Nov 4
2.73
1
18
39495866
Enhancing SARS-CoV-2 Lineage Surveillance through the Integration of a Simple and Direct qPCR-Based Protocol Adaptation with Established Machine Learning Algorithms.
Anal Chem
2024 Nov 4
6.37
1
19
39487761
Identification of catechin as main protease inhibitor of SARS-CoV-2 Omicron variant using molecular docking, molecular dynamics, PCA, DCCM, MM/GBSA and ADMET profiling.
Nat Prod Res
2024 Nov 2
3.9
1
20
39543395
Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants.
EMBO J
2024 Nov 14
9.96
2
21
39541564
Discovery of Chalcone Derivatives as Bifunctional Molecules with Anti-SARS-CoV-2 and Anti-inflammatory Activities.
J Nat Prod
2024 Nov 14
1
22
39543481
Identifying COVID-19 variant through symptoms profile: Would it be possible? A rapid review.
BMC Infect Dis
2024 Nov 14
2.58
1
23
39543801
Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant.
Curr Pharm Des
2024 Nov 13
2.43
1
24
39535926
AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors.
J Chem Inf Model
2024 Nov 13
4.04
1
25
39508769
Analysis of the structure and interactions of the SARS-CoV-2 ORF7b accessory protein.
Proc Natl Acad Sci U S A
2024 Nov 12
9.35
1